| User's Publication |
|
21588
Miyako S, Koma YI, Nakanishi T, Tsukamoto S, Yamanaka K, Ishihara N, Azumi Y, Urakami S, Shimizu M, Kodama T, Nishio M, Shigeoka M, Kakeji Y, Yokozaki H.
Periostin in Cancer-Associated Fibroblasts Promotes Esophageal Squamous Cell Carcinoma Progression by Enhancing Cancer and Stromal Cell Migration.
Am J Pathol
2024
PubMed ID: 38320632
DOI: 10.1016/j.ajpath.2023.12.010
|
|
22247
Feng X, Chen J, Lian J, Dong T, Gao Y, Zhang X, Zhai Y, Zou B, Guo Y, Xu E, Cui Y, Zhang L.
The glycogene alterations and potential effects in esophageal squamous cell carcinoma.
Cell Mol Life Sci
2024
81(1)
PubMed ID: 39636330
DOI: 10.1007/s00018-024-05534-3
|
|
22302
Nakanishi T, Koma YI, Miyako S, Torigoe R, Yokoo H, Omori M, Yamanaka K, Ishihara N, Tsukamoto S, Kodama T, Nishio M, Shigeoka M, Yokozaki H, Kakeji Y.
AREG Upregulation in Cancer Cells via Direct Interaction with Cancer-Associated Fibroblasts Promotes Esophageal Squamous Cell Carcinoma Progression Through EGFR-Erk/p38 MAPK Signaling
Cells
2024
13(20):1733
PubMed ID: 39451251
DOI: 10.3390/cells13201733
|
|
19768
Tsukamoto S, Koma YI, Kitamura Y, Tanigawa K, Azumi Y, Miyako S, Urakami S, Hosono M, Kodama T, Nishio M, Shigeoka M, Yokozaki H.
Matrix Metalloproteinase 9 Induced in Esophageal Squamous Cell Carcinoma Cells via Close Contact with Tumor-Associated Macrophages Contributes to Cancer Progression and Poor Prognosis
Cancers (Basel)
2023
15(11):2987
PubMed ID: 37296952
DOI: 10.3390/cancers15112987
|
|
19965
Azumi Y, Koma YI, Tsukamoto S, Kitamura Y, Ishihara N, Yamanaka K, Nakanishi T, Miyako S, Urakami S, Tanigawa K, Kodama T, Nishio M, Shigeoka M, Kakeji Y, Yokozaki H.
IFI16 Induced by Direct Interaction between Esophageal Squamous Cell Carcinomas and Macrophages Promotes Tumor Progression via Secretion of IL-1α
Cells
2023
12(22):2603
PubMed ID: 37998338
DOI: 10.3390/cells12222603
|
|
21054
Kitamura Y, Koma YI, Tanigawa K, Tsukamoto S, Azumi Y, Miyako S, Urakami S, Kodama T, Nishio M, Shigeoka M, Kakeji Y, Yokozaki H.
Roles of IL-7R Induced by Interactions between Cancer Cells and Macrophages in the Progression of Esophageal Squamous Cell Carcinoma.
Cancers (Basel)
2023
15(2)
PubMed ID: 36672342
DOI: 10.3390/cancers15020394
|
|
21175
Zhang X, Wang Y, Zhang X, Shen Y, Yang K, Ma Q, Qiao Y, Shi J, Wang Y, Xu L, Yang B, Ge G, Hu L, Kong X, Yang C, Chen Y, Ding J, Meng L.
Intact regulation of G1/S transition renders esophageal squamous cell carcinoma sensitive to PI3Kα inhibitors.
Signal Transduct Target Ther
2023
8(1):153
PubMed ID: 37041169
DOI: 10.1038/s41392-023-01359-x
|
|
17546
Liu J, Liu ZX, Li JJ, Zeng ZL, Wang JH, Luo XJ, Wong CW, Zheng JB, Pu HY, Mo HY, Sheng H, Wu QN, Li H, Wan G, Li B, Wang DS, Xu RH, Ju HQ.
The macrophage-associated lncRNA MALR facilitates ILF3 liquid-liquid phase separation to promote HIF1α signaling in esophageal cancer
Cancer Res
2022
CAN-22-1922
PubMed ID: 36264156
DOI: 10.1158/0008-5472.CAN-22-1922
|
|
17547
Shimizu H, Katsurahara K, Inoue H, Shiozaki A, Kosuga T, Kudou M, Arita T, Konishi H, Komatsu S, Fujiwara H, Morinaga Y, Konishi E, Otsuji E.
NADPH Oxidase 2 Has a Crucial Role in Cell Cycle Progression of Esophageal Squamous Cell Carcinoma
Ann Surg Oncol
2022
29(13):8677-8687
PubMed ID: 35972670
DOI: 10.1245/s10434-022-12384-5
|
|
17598
Kim S, Kim GH, Park SJ, Kwon CH, I H, Lee MW, Lee BE.
Exosomal MicroRNA Analyses in Esophageal Squamous Cell Carcinoma Cell Lines
J Clin Med
2022
11(15):4426
PubMed ID: 35956043
DOI: 10.3390/jcm11154426
|
|
17703
Tanigawa K, Tsukamoto S, Koma YI, Kitamura Y, Urakami S, Shimizu M, Fujikawa M, Kodama T, Nishio M, Shigeoka M, Kakeji Y, Yokozaki H.
S100A8/A9 Induced by Interaction with Macrophages in Esophageal Squamous Cell Carcinoma Promotes the Migration and Invasion of Cancer Cells via Akt and p38 MAPK Pathways
Am J Pathol
2022
192(3):536-552
PubMed ID: 34954212
DOI: 10.1016/j.ajpath.2021.12.002
|
|
20614
Tsuchihashi K, Hirata Y, Yamasaki J, Suina K, Tanoue K, Yae T, Masuda K, Baba E, Akashi K, Kitagawa Y, Saya H, Nagano O.
Presence of spontaneous epithelial-mesenchymal plasticity in esophageal cancer.
Biochem Biophys Rep
2022
30:101246
PubMed ID: 35330672
DOI: 10.1016/j.bbrep.2022.101246
|
|
20714
Zhai Y, Shan C, Zhang H, Kong P, Zhang L, Wang Y, Hu X, Cheng X.
FAT1 downregulation enhances stemness and cisplatin resistance in esophageal squamous cell carcinoma.
Mol Cell Biochem
2022
PubMed ID: 35606602
DOI: 10.1007/s11010-022-04475-4
|
|
13383
Sakamoto H, Koma YI, Higashino N, Kodama T, Tanigawa K, Shimizu M, Fujikawa M, Nishio M, Shigeoka M, Kakeji Y, Yokozaki H.
PAI-1 derived from cancer-associated fibroblasts in esophageal squamous cell carcinoma promotes the invasion of cancer cells and the migration of macrophages.
Lab Invest
2021
101(3):353-368
PubMed ID: 33311557
DOI: 10.1038/s41374-020-00512-2
|
|
20015
Fujikawa M, Koma YI, Hosono M, Urakawa N, Tanigawa K, Shimizu M, Kodama T, Sakamoto H, Nishio M, Shigeoka M, Kakeji Y, Yokozaki H.
Chemokine (C-C Motif) Ligand 1 Derived from Tumor-Associated Macrophages Contributes to Esophageal Squamous Cell Carcinoma Progression via CCR8-Mediated Akt/Proline-Rich Akt Substrate of 40 kDa/Mammalian Target of Rapamycin Pathway.
Am J Pathol
2021
PubMed ID: 33460563
DOI: 10.1016/j.ajpath.2021.01.004
|
|
20046
Mitsuda M, Shiozaki A, Kudou M, Shimizu H, Arita T, Kosuga T, Konishi H, Komatsu S, Kubota T, Fujiwara H, Okamoto K, Kishimoto M, Konishi E, Otsuji E.
Functional Analysis and Clinical Significance of Chloride Channel 2 Expression in Esophageal Squamous Cell Carcinoma.
Ann Surg Oncol
2021
PubMed ID: 33565032
DOI: 10.1245/s10434-021-09659-8
|
|
20071
Matsumoto Y, Shiozaki A, Kosuga T, Kudou M, Shimizu H, Arita T, Konishi H, Komatsu S, Kubota T, Fujiwara H, Okamoto K, Kishimoto M, Konishi E, Otsuji E.
Expression and Role of CFTR in Human Esophageal Squamous Cell Carcinoma.
Ann Surg Oncol
2021
PubMed ID: 33710504
DOI: 10.1245/s10434-021-09752-y
|
|
16116
Kobayashi T, Makino T, Yamashita K, Saito T, Tanaka K, Takahashi T, Kurokawa Y, Yamasaki M, Nakajima K, Morii E, Eguchi H, Doki Y.
APR-246 induces apoptosis and enhances chemo-sensitivity via activation of ROS and TAp73-Noxa signal in oesophageal squamous cell cancer with TP53 missense mutation
Br J Cancer
2021
125(11):1523-1532
PubMed ID: 34599296
DOI: 10.1038/s41416-021-01561-0
|
|
13045
Kodama T, Koma YI, Arai N, Kido A, Urakawa N, Nishio M, Shigeoka M, Yokozaki H.
CCL3-CCR5 axis contributes to progression of esophageal squamous cell carcinoma by promoting cell migration and invasion via Akt and ERK pathways.
Lab Invest
2020
PubMed ID: 32457351
DOI: 10.1038/s41374-020-0441-4
|
|
13092
Feng Y, Yan S, Huang Y, Huang Q, Wang F, Lei Y.
High expression of RABL6 promotes cell proliferation and predicts poor prognosis in esophageal squamous cell carcinoma.
BMC Cancer
2020
PubMed ID: 32600359
DOI: 10.1186/s12885-020-07068-w
|
|
13609
Okamoto M, Koma YI, Kodama T, Nishio M, Shigeoka M, Yokozaki H.
Growth Differentiation Factor 15 Promotes Progression of Esophageal Squamous Cell Carcinoma via TGF-β Type II Receptor Activation
Pathobiology
2020
87(2):100-113
PubMed ID: 31896114
DOI: 10.1159/000504394
|
|
11432
Kodaira H, Koma YI, Hosono M, Higashino N, Suemune K, Nishio M, Shigeoka M, Yokozaki H.
ANXA10 induction by interaction with tumor-associated macrophages promotes the growth of esophageal squamous cell carcinoma.
Pathol. Int.
2019
PubMed ID: 30758105
DOI: 10.1111/pin.12771
|
|
11583
Shi JJ, Xing H, Wang YX, Zhang X, Zhan QM, Geng MY, Ding J, Meng LH.
PI3Kα inhibitors sensitize esophageal squamous cell carcinoma to radiation by abrogating survival signals in tumor cells and tumor microenvironment.
Cancer Lett.
2019
PubMed ID: 31173854
DOI: 10.1016/j.canlet.2019.05.040
|
|
11631
Konishi T, Shiozaki A, Kosuga T, Kudou M, Shoda K, Arita T, Konishi H, Komatsu S, Kubota T, Fujiwara H, Okamoto K, Kishimoto M, Konishi E, Marunaka Y, Otsuji E.
LRRC8A Expression Influences Growth of Esophageal Squamous Cell Carcinoma.
Am. J. Pathol.
2019
PubMed ID: 31323188
DOI: 10.1016/j.ajpath.2019.06.006
|
|
11699
Kiyozumi Y, Baba Y, Okadome K, Yagi T, Ogata Y, Eto K, Hiyoshi Y, Ishimoto T, Iwatsuki M, Iwagami S, Miyamoto Y, Yoshida N, Watanabe M, Baba H.
Indoleamine 2, 3-dioxygenase 1 promoter hypomethylation is associated with poor prognosis in patients with esophageal cancer.
Cancer Sci
2019
110(6):1863-1871
PubMed ID: 31012515
DOI: 10.1111/cas.14028
|
|
12594
Kalikawe R, Baba Y, Nomoto D, Okadome K, Miyake K, Eto K, Hiyoshi Y, Nagai Y, Iwatsuki M, Ishimoto T, Iwagami S, Miyamoto Y, Yoshida N, Watanabe M, Baba H.
Lysyl oxidase impacts disease outcomes and correlates with global DNA hypomethylation in esophageal cancer
Cancer Sci
2019
110(12):3727-3737
PubMed ID: 31599475
DOI: 10.1111/cas.14214
|
|
10798
Shinno N, Kimura H, Sada R, Takiguchi S, Mori M, Fumoto K, Doki Y, Kikuchi A.
Activation of the Dickkopf1-CKAP4 pathway is associated with poor prognosis of esophageal cancer and anti-CKAP4 antibody may be a new therapeutic drug.
Oncogene
2018
37(26):3471-3484
PubMed ID: 29563607
DOI: 10.1038/s41388-018-0179-2
|
|
4355
Furukawa H, Makino T, Yamasaki M, Tanaka K, Miyazaki Y, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M, Doki Y.
PRIMA-1 induces p53-mediated apoptosis by upregulating Noxa in esophageal squamous cell carcinoma with TP53 missense mutation.
Cancer Sci.
2018
109(2):412-421
PubMed ID: 29168598
DOI: 10.1111/cas.13454
|
|
4357
Kim MJ, Choi SK, Hong SH, Eun JW, Nam SW, Han JW, You JS.
Oncogenic IL7R is downregulated by histone deacetylase inhibitor in esophageal squamous cell carcinoma via modulation of acetylated FOXO1.
Int. J. Oncol.
2018
53(1):395-403
PubMed ID: 29749437
DOI: 10.3892/ijo.2018.4392
|
|
9448
Chihiro Kajiwara, Katsumi Fumoto, Hirokazu Kimura, Satoshi Nojima, Keita Asano, Kazuki Odagiri, Makoto Yamasaki, Hayato Hikita, Tetsuo Takehara, Yuichiro Doki, Eiichi Morii, Akira Kikuchii
p63-Dependent Dickkopf3 Expression Promotes Esophageal Cancer Cell Proliferation via CKAP4
Cancer Res
2018
78(21):6107-6120
PubMed ID: 30181180
DOI: 10.1158/0008-5472.CAN-18-1749
|
|
14899
Shiozaki A, Hikami S, Ichikawa D, Kosuga T, Shimizu H, Kudou M, Yamazato Y, Kobayashi T, Shoda K, Arita T, Konishi H, Komatsu S, Kubota T, Fujiwara H, Okamoto K, Kishimoto M, Konishi E, Marunaka Y, Otsuji E.
Anion exchanger 2 suppresses cellular movement and has prognostic significance in esophageal squamous cell carcinoma
Oncotarget
2018
9(40):25993-26006
PubMed ID: 29899837
DOI: 10.18632/oncotarget.25417
|
|
10004
Iwaya T, Sawada G, Amano S, Kume K, Ito C, Endo F, Konosu M, Shioi Y, Akiyama Y, Takahara T, Otsuka K, Nitta H, Koeda K, Mizuno M, Nishizuka S, Sasaki A, Mimori K.
Downregulation of ST6GALNAC1 is associated with esophageal squamous cell carcinoma development.
Int. J. Oncol.
2017
50:441-447
PubMed ID: 28035351
DOI: 10.3892/ijo.2016.3817
|
|
10141
Sugase T, Takahashi T, Serada S, Nakatsuka R, Fujimoto M, Ohkawara T, Hara H, Nishigaki T, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Nakajima K, Takiguchi S, Kishimoto T, Mori M, Doki Y, Naka T.
Suppressor of cytokine signaling-1 gene therapy induces potent antitumor effect in patient-derived esophageal squamous cell carcinoma xenograft mice.
Int. J. Cancer
2017
140:2608-2621
PubMed ID: 28233302
DOI: 10.1002/ijc.30666
|
|
10323
Liu K, Song G, Zhang X, Li Q, Zhao Y, Zhou Y, Xiong R, Hu X, Tang Z, Feng G.
PTK7 is a novel oncogenic target for esophageal squamous cell carcinoma.
World J Surg Oncol
2017
15:105
PubMed ID: 28545451
DOI: 10.1186/s12957-017-1172-x
|
|
10353
Kawaguchi T, Komatsu S, Ichikawa D, Hirajima S, Nishimura Y, Konishi H, Shiozaki A, Fujiwara H, Okamoto K, Tsuda H, Otsuji E.
Overexpression of TRIM44 is related to invasive potential and malignant outcomes in esophageal squamous cell carcinoma.
Tumour Biol.
2017
39:1010428317700409
PubMed ID: 28618928
DOI: 10.1177/1010428317700409
|
|
10365
Yamamoto M, Yamasaki M, Tsukao Y, Tanaka K, Miyazaki Y, Makino T, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M, Doki Y.
Poly (ADP-ribose) polymerase-1 inhibition decreases proliferation through G2/M arrest in esophageal squamous cell carcinoma.
Oncol Lett
2017
14:1581-1587
PubMed ID: 28789382
DOI: 10.3892/ol.2017.6334
|
|
10692
Hosono M, Koma YI, Takase N, Urakawa N, Higashino N, Suemune K, Kodaira H, Nishio M, Shigeoka M, Kakeji Y, Yokozaki H.
CXCL8 derived from tumor-associated macrophages and esophageal squamous cell carcinomas contributes to tumor progression by promoting migration and invasion of cancer cells.
Oncotarget
2017
8:106071-106088
PubMed ID: 29285315
DOI: 10.18632/oncotarget.22526
|
|
14243
Shiozaki A, Kudou M, Ichikawa D, Shimizu H, Arita T, Kosuga T, Konishi H, Komatsu S, Fujiwara H, Okamoto K, Kishimoto M, Marunaka Y, Otsuji E.
Expression and role of anion exchanger 1 in esophageal squamous cell carcinoma
Oncotarget
2017
8(11):17921-17935
PubMed ID: 28160546
DOI: 10.18632/oncotarget.14900
|
|
9656
Nakahara Y, Yamasaki M, Sawada G, Miyazaki Y, Makino T, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mimori K, Mori M, Doki Y.
Downregulation of SIRT4 Expression Is Associated with Poor Prognosis in Esophageal Squamous Cell Carcinoma.
Oncology
2016
90:347-55
PubMed ID: 27082627
DOI: 10.1159/000445323
|
|
9724
Hara H, Takahashi T, Serada S, Fujimoto M, Ohkawara T, Nakatsuka R, Harada E, Nishigaki T, Takahashi Y, Nojima S, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Miyata H, Nakajima K, Takiguchi S, Morii E, Mori M, Doki Y, Naka T.
Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma.
Br. J. Cancer
2016
115:66-75
PubMed ID: 27310703
DOI: 10.1038/bjc.2016.183
|
|
12638
Nakayama A, Aoki S, Uchihashi K, Nishijima-Matsunobu A, Yamamoto M, Kakihara N, Iwakiri R, Fujimoto K, Toda S.
Interaction between Esophageal Squamous Cell Carcinoma and Adipose Tissue in Vitro
Am J Pathol
2016
186(5):1180-94
PubMed ID: 26952643
DOI: 10.1016/j.ajpath.2016.01.003
|
|
12664
Shin WS, Hong Y, Lee HW, Lee ST.
Catalytically defective receptor protein tyrosine kinase PTK7 enhances invasive phenotype by inducing MMP-9 through activation of AP-1 and NF-κB in esophageal squamous cell carcinoma cells
Oncotarget
2016
7(45):73242-73256
PubMed ID: 27689325
DOI: 10.18632/oncotarget.12303
|
|
12903
Nishio M, Urakawa N, Shigeoka M, Takase N, Ichihara Y, Arai N, Koma Y, Yokozaki H.
Software-assisted morphometric and phenotype analyses of human peripheral blood monocyte-derived macrophages induced by a microenvironment model of human esophageal squamous cell carcinoma
Pathol Int
2016
66(2):83-93
PubMed ID: 26778807
DOI: 10.1111/pin.12381
|
|
12969
Hamada J, Shoda K, Masuda K, Fujita Y, Naruto T, Kohmoto T, Miyakami Y, Watanabe M, Kudo Y, Fujiwara H, Ichikawa D, Otsuji E, Imoto I.
Tumor-promoting function and prognostic significance of the RNA-binding protein T-cell intracellular antigen-1 in esophageal squamous cell carcinoma
Oncotarget
2016
7(13):17111-28
PubMed ID: 26958940
DOI: 10.18632/oncotarget.7937
|
|
13973
Takase N, Koma Y, Urakawa N, Nishio M, Arai N, Akiyama H, Shigeoka M, Kakeji Y, Yokozaki H.
NCAM- and FGF-2-mediated FGFR1 signaling in the tumor microenvironment of esophageal cancer regulates the survival and migration of tumor-associated macrophages and cancer cells
Cancer Lett
2016
380(1):47-58
PubMed ID: 27317650
DOI: 10.1016/j.canlet.2016.06.009
|
|
13992
Nakamura K, Baba Y, Kosumi K, Harada K, Shigaki H, Miyake K, Kiyozumi Y, Ohuchi M, Kurashige J, Ishimoto T, Iwatsuki M, Sakamoto Y, Yoshida N, Watanabe M, Nakao M, Baba H.
UHRF1 regulates global DNA hypomethylation and is associated with poor prognosis in esophageal squamous cell carcinoma
Oncotarget
2016
7(36):57821-5783
PubMed ID: 27507047
DOI: 10.18632/oncotarget.11067
|
|
14108
Osako Y, Seki N, Kita Y, Yonemori K, Koshizuka K, Kurozumi A, Omoto I, Sasaki K, Uchikado Y, Kurahara H, Maemura K, Natsugoe S.
Regulation of MMP13 by antitumor microRNA-375 markedly inhibits cancer cell migration and invasion in esophageal squamous cell carcinoma
Int J Oncol
2016
49(6):2255-2264
PubMed ID: 27779648
DOI: 10.3892/ijo.2016.3745
|
|
14119
Park M, Yoon HJ, Kang MC, Kwon J, Lee HW.
PTK7 regulates radioresistance through nuclear factor-kappa B in esophageal squamous cell carcinoma
Tumour Biol
2016
37(10):14217-14224
PubMed ID: 27557627
DOI: 10.1007/s13277-016-5288-3
|
|
7350
Nabeki B, Ishigami S, Uchikado Y, Sasaki K, Kita Y, Okumura H, Arigami T, Kijima Y, Kurahara H, Maemura K, Natsugoe S.
Interleukin-32 expression and Treg infiltration in esophageal squamous cell carcinoma.
Anticancer Res.
2015
35:2941-7
PubMed ID: 25964580
|
|
7382
Saito S, Morishima K, Ui T, Hoshino H, Matsubara D, Ishikawa S, Aburatani H, Fukayama M, Hosoya Y, Sata N, Lefor AK, Yasuda Y, Niki T.
The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and lapatinib-resistance of esophageal squamous cell carcinoma.
BMC Cancer
2015
15:82
PubMed ID: 25884729
DOI: 10.1186/s12885-015-1065-8
|
|
7493
Wakita A, Motoyama S, Sato Y, Koyota S, Usami S, Yoshino K, Sasaki T, Imai K, Saito H, Minamiya Y.
REG Iα activates c-Jun through MAPK pathways to enhance the radiosensitivity of squamous esophageal cancer cells.
Tumour Biol.
2015
36:5249-54
PubMed ID: 25656613
DOI: 10.1007/s13277-015-3183-y
|
|
15184
Harada K, Baba Y, Ishimoto T, Kosumi K, Tokunaga R, Izumi D, Ohuchi M, Nakamura K, Kiyozumi Y, Kurashige J, Iwagami S, Miyamoto Y, Sakamoto Y, Yoshida N, Oki E, Watanabe M, Baba H.
Suppressor microRNA-145 Is Epigenetically Regulated by Promoter Hypermethylation in Esophageal Squamous Cell Carcinom
Anticancer Res
2015
35(9):4617-24
PubMed ID: 26254350
|
|
15226
Matsushita D, Uenosono Y, Arigami T, Yanagita S, Nishizono Y, Hagihara T, Hirata M, Haraguchi N, Arima H, Kijima Y, Kurahara H, Maemura K, Okumura H, Ishigami S, Natsugoe S.
Clinical Significance of Circulating Tumor Cells in Peripheral Blood of Patients with Esophageal Squamous Cell Carcinoma
Ann Surg Oncol
2015
22(11):3674-80
PubMed ID: 25652049
DOI: 10.1245/s10434-015-4392-8
|
|
15229
Shigeoka M, Urakawa N, Nishio M, Takase N, Utsunomiya S, Akiyama H, Kakeji Y, Komori T, Koma Y, Yokozaki H.
Cyr61 promotes CD204 expression and the migration of macrophages via MEK/ERK pathway in esophageal squamous cell carcinoma
Cancer Med
2015
4(3):437-46
PubMed ID: 25620088
DOI: 10.1002/cam4.401
|
|
15232
Urakawa N, Utsunomiya S, Nishio M, Shigeoka M, Takase N, Arai N, Kakeji Y, Koma Y, Yokozaki H.
GDF15 derived from both tumor-associated macrophages and esophageal squamous cell carcinomas contributes to tumor progression via Akt and Erk pathways
Lab Invest
2015
95(5):491-503
PubMed ID: 25730371
DOI: 10.1038/labinvest.2015.36
|
|
19049
Kwon J, Yoon HJ, Kim JH, Lee TS, Song IH, Lee HW, Kang MC, Park JH.
Cetuximab inhibits cisplatin-induced activation of EGFR signaling in esophageal squamous cell carcinoma
Oncol Rep
2014
32(3):1188-92
PubMed ID: 24993015
DOI: 10.3892/or.2014.3302
|
|
13765
Sawayama H, Ishimoto T, Watanabe M, Yoshida N, Sugihara H, Kurashige J, Hirashima K, Iwatsuki M, Baba Y, Oki E, Morita M, Shiose Y, Baba H.
Small molecule agonists of PPAR-γ exert therapeutic effects in esophageal cancer
Cancer Res
2014
74(2):575-85
PubMed ID: 24272485
DOI: 10.1158/0008-5472.CAN-13-1836
|
|
17149
Yeo SY, Ha SY, Yu EJ, Lee KW, Kim JH, Kim SH.
ZNF282 (Zinc finger protein 282), a novel E2F1 co-activator, pr
Oncotarget
2014
5(23):12260-72
PubMed ID: 25373738
DOI: 10.18632/oncotarget.2630
|
|
16294
Britschgi A, Bill A, Brinkhaus H, Rothwell C, Clay I, Duss S, Rebhan M, Raman P, Guy CT, Wetzel K, George E, Popa MO, Lilley S, Choudhury H, Gosling M, Wang L, Fitzgerald S, Borawski J, Baffoe J, Labow M, Gaither LA, Bentires-Alj M.
Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling
Proc Natl Acad Sci U S A
2013
110(11):E1026-34
PubMed ID: 23431153
DOI: 10.1073/pnas.1217072110
|
|
18742
Sugimura K, Miyata H, Tanaka K, Hamano R, Takahashi T, Kurokawa Y, Yamasaki M, Nakajima K, Takiguchi S, Mori M, Doki Y.
Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma
Clin Cancer Res
2012
18(18):5144-53
PubMed ID: 22847808
DOI: 10.1158/1078-0432.CCR-12-0701
|
|
8377
Usami S, Motoyama S, Koyota S, Wang J, Hayashi-Shibuya K, Maruyama K, Takahashi N, Saito H, Minamiya Y, Takasawa S, Ogawa J, Sugiyama T.
Regenerating gene I regulates interleukin-6 production in squamous esophageal cancer cells.
Biochem. Biophys. Res. Commun.
2010
392:4-8
PubMed ID: 20056108
DOI: 10.1016/j.bbrc.2009.12.129
|
|
8430
Ooki A, Yamashita K, Kikuchi S, Sakuramoto S, Katada N, Watanabe M.
Phosphatase of regenerating liver-3 as a convergent therapeutic target for lymph node metastasis in esophageal squamous cell carcinoma.
Int. J. Cancer
2010
127:543-54
PubMed ID: 19960436
DOI: 10.1002/ijc.25082
|
|
18707
Rahadiani N, Ikeda J, Makino T, Tian T, Qiu Y, Mamat S, Wang Y, Doki Y, Aozasa K, Morii E.
Tumorigenic role of podoplanin in esophageal squamous-cell carcinoma
Ann Surg Oncol
2010
17(5):1311-23
PubMed ID: 20066519
DOI: 10.1245/s10434-009-0895-5
|
Back
Top
CELL BANK Website
